Sei Yonezawa

1.0k total citations · 1 hit paper
29 papers, 807 citations indexed

About

Sei Yonezawa is a scholar working on Molecular Biology, Biomaterials and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sei Yonezawa has authored 29 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Biomaterials and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sei Yonezawa's work include RNA Interference and Gene Delivery (10 papers), Lipid Membrane Structure and Behavior (7 papers) and Nanoparticle-Based Drug Delivery (7 papers). Sei Yonezawa is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Lipid Membrane Structure and Behavior (7 papers) and Nanoparticle-Based Drug Delivery (7 papers). Sei Yonezawa collaborates with scholars based in Japan, United Kingdom and Thailand. Sei Yonezawa's co-authors include Tomohiro Asai, Hiroyuki Koide, Naoto Oku, Kanae Ichikawa, Yoshito Takeuchi, Yukihiro Namba, Kohta Kurohane, Mamoru Nango, Kosuke Shimizu and Tomoya Hikita and has published in prestigious journals such as Advanced Functional Materials, Cancer and Advanced Drug Delivery Reviews.

In The Last Decade

Sei Yonezawa

28 papers receiving 794 citations

Hit Papers

Recent advances in siRNA delivery mediated by lipid-based... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers

Sei Yonezawa
Sei Yonezawa
Citations per year, relative to Sei Yonezawa Sei Yonezawa (= 1×) peers Wenhui Tao

Countries citing papers authored by Sei Yonezawa

Since Specialization
Citations

This map shows the geographic impact of Sei Yonezawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sei Yonezawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sei Yonezawa more than expected).

Fields of papers citing papers by Sei Yonezawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sei Yonezawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sei Yonezawa. The network helps show where Sei Yonezawa may publish in the future.

Co-authorship network of co-authors of Sei Yonezawa

This figure shows the co-authorship network connecting the top 25 collaborators of Sei Yonezawa. A scholar is included among the top collaborators of Sei Yonezawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sei Yonezawa. Sei Yonezawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Sayaka, et al.. (2025). Development of a messenger RNA vaccine using pH-responsive dipeptide-conjugated lipids exhibiting reduced inflammatory properties. International Journal of Pharmaceutics. 674. 125485–125485.
2.
Koide, Hiroyuki, Shinya Hirata, Hiroki Ochiai, et al.. (2025). In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for sepsis therapy. Journal of Controlled Release. 382. 113734–113734. 1 indexed citations
3.
Koide, Hiroyuki, et al.. (2024). Delivery of small interfering ribonucleic acid using lipid nanoparticles prepared with pH-responsive dipeptide-conjugated lipids. Biochemical and Biophysical Research Communications. 729. 150372–150372. 1 indexed citations
4.
Yonezawa, Sei, Yasushi Kawasaki, Yasuhiro Natori, & Akinori Sugiyama. (2023). Improvement of LXR-mediated lipid metabolism in nephrotic model kidney accompanied by suppression of inflammation and fibrosis. Biochemical and Biophysical Research Communications. 666. 122–127. 5 indexed citations
5.
Koide, Hiroyuki, Kazuhiro Saito, Keiichi Yoshimatsu, et al.. (2023). Cooling-induced, localized release of cytotoxic peptides from engineered polymer nanoparticles in living mice for cancer therapy. Journal of Controlled Release. 355. 745–759. 9 indexed citations
6.
Koide, Hiroyuki, Hiroki Ochiai, Shinya Hirata, et al.. (2022). Easy preparation of a liposome-mediated protein delivery system by freeze–thawing a liposome–protein complex. Journal of Materials Chemistry B. 10(35). 6768–6776. 9 indexed citations
7.
Koide, Hiroyuki, Sei Yonezawa, & Tomohiro Asai. (2021). siRNA Vehicles for High Endosomal Escapability. Methods in molecular biology. 2282. 171–179. 1 indexed citations
8.
Yonezawa, Sei, Hiroyuki Koide, & Tomohiro Asai. (2020). Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Advanced Drug Delivery Reviews. 154-155. 64–78. 298 indexed citations breakdown →
9.
Yonezawa, Sei, et al.. (2018). Each liver X receptor (LXR) type has a different purpose in different situations. Biochemical and Biophysical Research Communications. 508(1). 92–96. 4 indexed citations
10.
Kawasaki, Yasushi, et al.. (2015). Angiostatin prevents IL-1β-induced down-regulation of eNOS expression by inhibiting the NF-κB cascade. Journal of Pharmacological Sciences. 129(3). 200–204. 12 indexed citations
11.
Ichikawa, Kanae, Tomohiro Asai, Kosuke Shimizu, et al.. (2013). Suppression of immune response by antigen-modified liposomes encapsulating model agents: A novel strategy for the treatment of allergy. Journal of Controlled Release. 167(3). 284–289. 14 indexed citations
12.
Asai, Tomohiro, Yuko Suzuki, Sei Yonezawa, et al.. (2008). Disappearance of the angiogenic potential of endothelial cells caused by Argonaute2 knockdown. Biochemical and Biophysical Research Communications. 368(2). 243–248. 35 indexed citations
13.
Yonezawa, Sei, Tomohiro Asai, & Naoto Oku. (2007). Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor model. Journal of Controlled Release. 118(3). 303–309. 13 indexed citations
14.
Ichikawa, Kanae, et al.. (2006). Enhanced desensitization efficacy by liposomal conjugation of a specific antigen. International Journal of Pharmaceutics. 336(2). 391–395. 6 indexed citations
15.
Siripong, Pongpun, Kosuke Shimizu, Kanae Ichikawa, et al.. (2006). Antitumor Activity of Liposomal Naphthoquinone Esters Isolated from Thai Medicinal Plant: Rhinacanthus nasutus KURZ.. Biological and Pharmaceutical Bulletin. 29(11). 2279–2283. 44 indexed citations
16.
Ichikawa, Kanae, Tomoya Hikita, Noriyuki Maeda, et al.. (2005). Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1669(1). 69–74. 61 indexed citations
17.
Takeuchi, Yoshito, Kanae Ichikawa, Sei Yonezawa, et al.. (2004). Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome. Journal of Controlled Release. 97(2). 231–240. 64 indexed citations
18.
Imanaka, Hiromichi, et al.. (2004). Suppressed Permeation of Linoleic Acid in a Liposomal Formulation through Reconstructed Skin Tissue. Biological and Pharmaceutical Bulletin. 27(6). 879–882. 8 indexed citations
19.
Ichikawa, Kanae, Yoshito Takeuchi, Sei Yonezawa, et al.. (2003). Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Cancer Letters. 205(1). 39–48. 53 indexed citations
20.
Takeuchi, Yoshito, Kohta Kurohane, Kanae Ichikawa, et al.. (2003). Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation‐modified liposomal photosensitizer. Cancer. 97(8). 2027–2034. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026